Urine proteome changes in a chronic unpredictable mild stress (CUMS) mouse model of major depressive disorder

Yuhang Huan1, Jing Wei1, Tong Su2

  • 1Department of Biochemistry and Molecular Biology, Beijing Normal University, Gene Engineering Drug and Biotechnology Beijing Key Laboratory, Beijing, 100875, China.

Insights

Researchers identified key urine protein changes in a mouse model of major depressive disorder (MDD). These findings offer potential biomarkers for diagnosing MDD, a condition lacking effective diagnostic tools.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Major depressive disorder (MDD) is a widespread psychiatric condition lacking reliable diagnostic biomarkers.
  • Urine analysis offers a non-invasive method to detect disease-related physiological changes due to its lack of homeostatic regulation.

Purpose of the Study:

  • To investigate urine proteome alterations in a chronic unpredictable mild stress (CUMS) mouse model of MDD.
  • To identify potential urinary biomarkers for MDD diagnosis.

Main Methods:

  • Male C57BL/6 mice were exposed to CUMS for five weeks.
  • Depression-like behaviors were assessed using tail suspension and sucrose consumption tests.
  • Urine proteomes were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Main Results:

  • 36 differential proteins were identified in the urine of CUMS mice.
  • 19 of these proteins are linked to MDD pathogenesis.
  • Statistical analysis confirmed the reliability of the identified differential proteins, with over 95% confidence.

Conclusions:

  • Urine proteome changes in the CUMS model reflect MDD-associated alterations.
  • Identified differential proteins, particularly those related to blood coagulation, inflammation, and CNS development, may serve as potential diagnostic clues for MDD.

Related Concept Videos